Table 1 Summary of demographic, cardiorespiratory, mood, and global imaging study measures for 10 participants scanned before and after COVID-19 infection.

From: Brain temperature and free water increases after mild COVID-19 infection

 

Pre-COVID-19

Post-COVID-19

Group differences

Age (years)

Mean age at study visit

27.4 ± 6.1

29.9 ± 6.6

 

Cardiorespiratory metrics

 

Core body temperature (°C)

36.63 ± 0.18

36.67 ± 0.31

t(9) = 0.25, p = 0.40

 

Heart rate (bpm)

79.5 ± 13.3

79.7 ± 11.4

t(9) = 0.05, p = 0.48

 

Blood pressure, systolic

127.5 ± 13.6

121.2 ± 15.5

t(9) = 1.48, p = 0.09

 

Blood pressure, diastolic

74.7 ± 8.2

74.9 ± 6.8

t(9) = 0.16, p = 0.44

Mood metrics

Hospital Anxiety & Depression Scale (HADS)

HADS, depression subscale

2.4 ± 2.4

2.7 ± 2.2

t(9) = 0.47, p = 0.32

HADS, anxiety subscale

6.0 ± 2.1

7.3 ± 3.2

t(9) = 1.5, p = 0.08

Profile of Mood States (POMS)

Tension-anxiety

7.0 ± 5.1

11.9 ± 4.3

t(9) = 3.32, p = 0.004

Anger-hostility

5.6 ± 4.6

5.9 ± 3.6

t(9) = 0.26, p = 0.40

Depression-dejection

4.9 ± 3.3

5.1 ± 3.5

t(9) = 0.16, p = 0.44

 

Vigor-activity

19.2 ± 5.9

13.9 ± 6.2

t(9) = 3.12, p = 0.006

 

Confusion-bewilderment

4.9 ± 2.7

7.0 ± 3.4

t(9) = 1.62, p = 0.07

 

Fatigue-inertia

7.6 ± 4.6

10.1 ± 4.1

t(9) = 1.57, p = 0.08

 

Total mood disturbance (TMD)

10.8 ± 20.6

26.1 ± 9.7

t(9) = 2.29, p = 0.02

Neuroimaging metrics

Global (whole brain)

TIV (cm3)

1490.1 ± 173.5

1477.9 ± 169.0

t(9) = 0.29, p = 0.39

 

TCRE (°C)

35.70 ± 0.31

35.91 ± 0.31

t(9) = 1.55, p = 0.08

 

FISO

0.12 ± 0.12

0.15 ± 0.03

t(9) = 2.13, p = 0.03

 

FICVF

0.39 ± 0.02

0.39 ± 0.02

t(9) = 0.95, p = 0.18

 

ODI

0.39 ± 0.05

0.39 ± 0.02

t(9) = 0.14, p = 0.05

  1. Pre-COVID-19 data were collected twice, 12-weeks apart. Post-COVID-19 data were collected after resolution of infective period.
  2. Data are represented as mean ± standard deviation. For each study measure, participants’ pre-COVID-19 data represent the mean of data collected at two timepoints before COVID-19 infection. Core body temperature was measured using a tympanic thermometer. The mean and SD for global imaging metrics were calculated across all brain regions for each set of three-dimensional spatial maps. Total intracranial volume (TIV) Brain temperature was derived from MRSI-t data, and brain morphometric measures were calculated from structural MRI images.
  3. bpm beats per minute, HADS Hospital Anxiety and Depression Scale, POMS Profile of Mood States, TMD Total Mood Disturbance composite score on the POMS, TIV total intracranial volume, MRSI-t volumetric magnetic resonance spectroscopic imaging and thermometry, CRE creatine, TCRE brain temperature measured by MRSI-t with CRE as the reference metabolite, FISO fractional isotropic volume fraction, ODI orientation dispersion index, FICVF fractional intracellular volume fraction, GMV grey matter volume, olf olfactory, AON anterior olfactory nucleus, L left, R right.
  4. Significant values are in bold.